# Lenalidomide and Dexamethasone With/Without Stem Cell Transplant in Patients With Multiple Myeloma

> **NCT01731886** · PHASE4 · COMPLETED · sponsor: **Columbia University** · enrollment: 60 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **PROCEDURE:** Autologous peripheral blood stem cell transplant
- **DRUG:** Lenalidomide
- **DRUG:** Dexamethasone
- **PROCEDURE:** Stem cell collection
- **DRUG:** Melphalan
- **DRUG:** G-CSF
- **DRUG:** Cyclophosphamide
- **DRUG:** Mesna

## Key facts

- **NCT ID:** NCT01731886
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2017-04-11
- **Final completion:** 2017-04-11
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2020-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01731886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01731886, "Lenalidomide and Dexamethasone With/Without Stem Cell Transplant in Patients With Multiple Myeloma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01731886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*